COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,082 Articles (22,658 medRxiv, 8,424 bioRxiv)

Most recent first Previous |  Page 1937: Articles 19361-19370  | Next

Clinical outcomes and risk factors for COVID-19 among migrant populations in high-income countries: a systematic review
Hayward, S. E., Deal, A., Cheng, C., Crawshaw, A. F., Orcutt, M., Vandrevala, T. F., Norredam, M., Carballo, M., Ciftci, Y., Requena-Mendez, A., Greenaway, C., Carter, J., Knights, F., Mehrotra, A., Seedat, F., Bozorgmehr, K., Veizis, A., Campos-Matos, I., Wurie, F., Noori, T., McKee, M., Kumar, B., Hargreaves, S.
10.1101/2020.12.21.20248475 — Posted: 2020-12-22
SARS-CoV-2 neutralizing antibodies; longevity, breadth, and evasion by emerging viral variants
Tea, F., Ospina Stella, A., Aggarwal, A., Darley, D. R., Pilli, D., Vitale, D., Merheb, V., Lee, F. X. Z., Cunningham, P., Walker, G. J., Brown, D. A., Rawlinson, W. D., Isaacs, S. R., Mathivanan, V., Hoffman, M., Poehlmann, S., Dwyer, D. E., Rockett, R., Sintchenko, V., Hoad, V. C., Irving, D. O., Dore, G. J., Gosbell, I. B., Kelleher, A. D., Matthews, G. V., Brilot, F., Turville, S. G.
10.1101/2020.12.19.20248567 — Posted: 2020-12-22
Identification of SARS-CoV-2-specific immune alterations in acutely ill patients
Rebillard, R.-M., Charabati, M., Grasmuck, C., Filali-Mouhim, A., Tastet, O., Brassard, N., Daigneault, A., Bourbonniere, L., Balthazard, R., Carmena Moratalla, A., Carpentier Solorio, Y., Farzam-kia, N., Fournier, A. P., Gowing, E., Jamann, H., Lemaitre, F., Mamane, V. H., Thai, K., Cailhier, J.-F., Chomont, N., Finzi, A., Chasse, M., Durand, M., Arbour, N., Kaufmann, D. E., Prat, A., Larochelle, C.
10.1101/2020.12.21.20248642 — Posted: 2020-12-22
COVID-19 in-hospital mortality in South Africa: the intersection of communicable and non-communicable chronic diseases in a high HIV prevalence setting
JASSAT, W., Cohen, C., Masha, M., Goldstein, S., Kufa-Chakezha, T., Savulescu, D., Walaza, S., Bam, J.-L., Davies, M.-A., Prozesky, H. W., Naude, J., Mnguni, T., Lawrence, C. A., Mathema, H., Blumberg, L.
10.1101/2020.12.21.20248409 — Posted: 2020-12-22
Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD protein vaccine against COVID-19 in adults: pooled analysis of two randomized, double-blind, placebo-controlled, phase 1 and 2 trials
Yang, S., Li, Y., Dai, L., Wang, J., He, P., Li, C., Fang, X., Wang, C., Zhao, X., Huang, E., Wu, C., Zhong, Z., Wang, F., Duan, X., Tian, S., Wu, L., Liu, Y., Luo, Y., Chen, Z., Li, F., Li, J., Yu, X., Ren, H., Liu, L., Meng, S., Yan, J., Hu, Z., Gao, L., Gao, G. F.
10.1101/2020.12.20.20248602 — Posted: 2020-12-22 Discussion: Offsite
Changes in UK hospital mortality in the first wave of COVID-19: the ISARIC WHO Clinical Characterisation Protocol prospective multicentre observational cohort study
Docherty, A. B., Mulholland, R. H., Lone, N. I., Cheyne, C. P., De Angelis, D., Diaz-Ordaz, K., Donoghue, C., Drake, T. M., Dunning, J., Funk, S., Garcia-Finana, M., Girvan, M., Hardwick, H. E., Harrison, J., Ho, A., Hughes, D. M., Keogh, R. H., Kirwan, P. D., Leeming, G., Nguyen-Van-Tam, J. S., Pius, R., Russell, C. D., Spencer, R., Tom, B. D., Turtle, L., Openshaw, P. J., Baillie, J. K., Harrison, E. M., Semple, M. G.
10.1101/2020.12.19.20248559 — Posted: 2020-12-22
Predicting intention to receive COVID-19 vaccine among the general population using the Health Belief Model and the Theory of Planned Behavior Model
Shmueli, L.
10.1101/2020.12.20.20248587 — Posted: 2020-12-22
Immunogenicity and crossreactivity of antibodies to SARS-CoV-2 nucleocapsid protein
Dobano, C., Santano, R., Jimenez, A., Vidal, M., Chi, J., Rodrigo Melero, N., Popovic, M., Lopez-Aladid, R., Fernandez-Barat, L., Tortajada, M., Carmona-Torre, F., Reina, G., Torres, A., Mayor, A., Carolis, C., Garcia-Basteiro, A. L., Aguilar, R., Moncunill, G., Izquierdo, L.
10.1101/2020.12.19.20248551 — Posted: 2020-12-22
Development and Evaluation of Two Rapid Indigenous IgG-ELISA immobilized with ACE-2 Binding Peptides for Detection Neutralizing Antibodies Against SARS-CoV-2
Sil, B. K., Adnan, N., Oishee, M. J., Ali, T., Jahan, N., Khandker, S. S., Kobatake, E., Mie, M., Khondoker, D. M. U., Haq, M. A., Jamiruddin, M. R.
10.1101/2020.12.19.20248535 — Posted: 2020-12-22
How do Covid-19 policy options depend on end-of-year holiday contacts in Mexico City Metropolitan Area? A Modeling Study
Alarid-Escudero, F., Gracia, V., Luviano, A., Peralta, Y., Reitsma, M. B., Claypool, A. L., Salomon, J. A., Studdert, D. M., Andrews, J. R., Goldhaber-Fiebert, J. D., Stanford-CIDE Coronavirus Simulation Model (SC-COSMO) Modeling Consortium
10.1101/2020.12.21.20248597 — Posted: 2020-12-22

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).